| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 151, 1115-1122, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
M Arrasate, M Perez, JM Valpuesta and J Avila
Centro de Biologia Molecular (CSIC-UAM), Facultad de Ciencias, Universidad Autonoma de Madrid, Spain.
It is known from previous work that tau is the main component of paired helical filaments (PHFs) and that it can assemble in vitro into polymers resembling PHFs when high concentrations of protein are used. In the search for molecules that can facilitate tau polymerization, a component of neurofibrillary tangles, heparan sulfate (or its more sulfated form, heparin), and other glycosaminoglycans have been tested. Glycosaminoglycans, in the sulfated but not in the unsulfated form, facilitate not only tau assembly but also the formation of polymers resembling PHFs. Conversely, PHFs were found to contain heparan sulfate and chondroitin sulfate. Heparinase or chondroitinase treatment of PHFs results in the formation of straight structures. All of these results suggest a role for sulfated glycosaminoglycans in determining the helicity of PHFs.
This article has been cited by other articles:
 |
|
 |
|
  B. Kuhla, C. Haase, K. Flach, H.-J. Luth, T. Arendt, and G. Munch Effect of Pseudophosphorylation and Cross-linking by Lipid Peroxidation and Advanced Glycation End Product Precursors on Tau Aggregation and Filament Formation J. Biol. Chem., March 9, 2007; 282(10): 6984 - 6991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. AVILA, J. J. LUCAS, M. PEREZ, and F. HERNANDEZ Role of Tau Protein in Both Physiological and Pathological Conditions Physiol Rev, April 1, 2004; 84(2): 361 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Goedert and M. Hasegawa The Tauopathies : Toward an Experimental Animal Model Am. J. Pathol., January 1, 1999; 154(1): 1 - 6. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
